The effect of Monthly ibandronate iv injected on the low-responders to pre-existing oral BP treatment for the osteoporosis patients
Active, no longer recruiting
Phase of Trial: Phase III
Latest Information Update: 15 Apr 2017
At a glance
- Drugs Ibandronic acid (Primary)
- Indications Osteoporosis
- Focus Therapeutic Use
- Acronyms MOVEMENT
- 03 Apr 2017 Status changed from recruiting to active, no longer recruiting.
- 30 Oct 2015 Status changed from not yet recruiting to recruiting, as reported by University Hospital Medical Information Network - Japan.
- 10 Jun 2015 New trial record